Assessment of the mode of action underlying development of rodent small intestinal tumors following oral exposure to hexavalent chromium and relevance to humans

References

• Alexander J, Aaseth, J. (1995). Uptake of chromate in human red blood cells and isolated rat liver cells: the role of the anion carrier. Analyst, 120, 931–3
   PubMed Web of Science ®Google Scholar
• Amendola R, Santos MC, Massa JM, et al. (2007). Effects of a single low dose of ranitidine and effervescent antacids on intragastric acidity in healthy volunteers. Acta Gastroenterol Latinoam, 37, 231–7
   Google Scholar
• Ames BN, McCann J, Yamasaki E. (1975). Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat Res, 31, 347–64
   PubMed Web of Science ®Google Scholar
• Ames BN, Shigenaga MK, Gold LS. (1993). DNA lesions, inducible DNA repair, and cell division: three key factors in mutagenesis and carcinogenesis. Environ Health Perspect, 101, 35–44
   PubMed Web of Science ®Google Scholar
• Anderson RA. (2000). Chromium in the prevention and control of diabetes. Diabetes Metab, 26, 22–7
   PubMed Web of Science ®Google Scholar
• Arce GT, Gordon EB, Cohen SM, Singh, P. (2010). Genetic toxicology of folpet and captan. Crit Rev Toxicol, 40, 546–74
   PubMed Web of Science ®Google Scholar
• AWWA. (2004). Occurrence survey of boron and hexavalent chromium. Denver (CO): American Water Works Association Research Foundation
   Google Scholar
• Azad N, Iyer AK, Wang L, et al. (2010). Nitric oxide-mediated bcl-2 stabilization potentiates malignant transformation of human lung epithelial cells. Am J Respir Cell Mol Biol, 42, 578–85
   Google Scholar
• Azzolini C, Fiorani M, Guidarelli A, Cantoni O. (2011). Studies with low micromolar levels of ascorbic and dehydroascorbic acid fail to unravel a preferential route for vitamin C uptake and accumulation in U937 cells. Br J Nutr, 107, 691–6
   Google Scholar
• Bagchi D, Balmoori J, Bagchi M, et al. (2002). Comparative effects of TCDD, endrin, naphthalene and chromium (VI) on oxidative stress and tissue damage in the liver and brain tissues of mice. Toxicology. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol, 175, 73–82
   Google Scholar
• Bagchi D, Hassoun EA, Bagchi M, et al. (1995a). Oxidative stress induced by chronic administration of sodium dichromate [Cr(VI)] to rats. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol, 110, 281–7
   PubMedGoogle Scholar
• Bagchi D, Hassoun EA, Bagchi M, et al. (1995b). Chromium-induced excretion of urinary lipid metabolites, DNA damage, nitric oxide production, and generation of reactive oxygen species in Sprague-Dawley rats. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol, 110, 177–87
   PubMed Web of Science ®Google Scholar
• Bagchi D, Vuchetich PJ, Bagchi M, et al. (1997). Induction of oxidative stress by chronic administration of sodium dichromate [chromium VI] and cadmium chloride [cadmium II] to rats. Free Radic Biol Med, 22, 471–8
   PubMed Web of Science ®Google Scholar
• Barker N, Ridgway RA, van Es JH, et al. (2009). Crypt stem cells as the cells-of-origin of intestinal cancer. Nature, 457, 608–11
   PubMed Web of Science ®Google Scholar
• Beaver LM, Stemmy EJ, Schwartz AM, et al. (2009). Lung inflammation, injury, and proliferative response after repetitive particulate hexavalent chromium exposure. Environ Health Perspect, 117, 1896–902
   PubMed Web of Science ®Google Scholar
• Bennicelli C, Camoirano, A, Petruzzelli S, et al. (1983). High sensitivity of Salmonella TA102 in detecting hexavalent chromium mutagenicity and its reversal by liver and lung preparations. Mutat Res, 122, 1–5
   PubMed Web of Science ®Google Scholar
• Berlanga-Acosta J, Playford RJ, Mandir N, Goodlad RA. (2001). Gastrointestinal cell proliferation and crypt fission are separate but complementary means of increasing tissue mass following infusion of epidermal growth factor in rats. Gut, 48, 803–7
   Google Scholar
• Bernard B, Gordon E. (2000). An evaluation of the common mechanism approach to the food quality protection act: captan and four related fungicides, a practical example. Int J Toxicol, 19, 43–61
   Google Scholar
• Blakey DH, Duncan AM, Wargovich MJ, et al. (1985). Detection of nuclear anomalies in the colonic epithelium of the mouse. Cancer Res, 45, 242–9
   PubMed Web of Science ®Google Scholar
• Bonner WM, Redon CE, Dickey JS, et al. (2008). GammaH2AX and cancer. Nat Rev Cancer, 8, 957–67
   PubMed Web of Science ®Google Scholar
• Boobis AR, Cohen SM, Dellarco V, et al. (2006). IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit Rev Toxicol, 36, 781–92
   PubMed Web of Science ®Google Scholar
• Boobis AR, Doe JE, Heinrich-Hirsch B, et al. (2008). IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit Rev Toxicol, 38, 87–96
   PubMed Web of Science ®Google Scholar
• Boobis AR, Daston GP, Preston RJ, Olin SS. (2009). Application of key events analysis to chemical carcinogens and noncarcinogens. Crit Rev Food Sci Nutr, 49, 690–707
   PubMed Web of Science ®Google Scholar
• Buttner B, Beyersmann D. (1985). Modification of the erythrocyte anion carrier by chromate. Xenobiotica, 15, 735–41
   PubMed Web of Science ®Google Scholar
• Campbell CE, Gravel RA, Worton RG. (1981). Isolation and characterization of Chinese hamster cell mutants resistant to the cytotoxic effects of chromate. Somatic Cell Genet, 7, 535–46
   PubMedGoogle Scholar
• Castellano E, Santos E. (2011). Functional specificity of ras isoforms: so similar but so different. Genes Cancer, 2, 216–31
   PubMedGoogle Scholar
• CDPH. (2011). Chromium-6 in drinking water: an overview of sampling results. California: California Department of Public Health
   Google Scholar
• Celik A, Mazmanci B, Camlica Y, et al. (2005). Induction of micronuclei by lambda-cyhalothrin in Wistar rat bone marrow and gut epithelial cells. Mutagenesis, 20, 125–9
   PubMed Web of Science ®Google Scholar
• Chandra SA, Nolan MW, Malarkey DE. (2010). Chemical carcinogenesis of the gastrointestinal tract in rodents: an overview with emphasis on NTP carcinogenesis bioassays. Toxicol Pathol, 38, 188–97
   PubMed Web of Science ®Google Scholar
• Chen Q, Espey MG, Krishna MC, et al. (2005). Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci USA, 102, 13604–9
   PubMed Web of Science ®Google Scholar
• Cheng L, Sonntag DM, de Boer J, Dixon, K. (2000). Chromium(VI)-induced mutagenesis in the lungs of big blue transgenic mice. J Environ Pathol Toxicol Oncol, 19, 239–49
   PubMedGoogle Scholar
• Chidiac P, Goldberg MT. (1987). Lack of induction of nuclear aberrations by captan in mouse duodenum. Environ Mutagen, 9, 297–306
   PubMedGoogle Scholar
• Chiu A, Shi XL, Lee WK, et al. (2010). Review of chromium (VI) apoptosis, cell-cycle-arrest, and carcinogenesis. J Environ Sci Health. Part C, Environ Carcinog Ecotoxicol Rev, 28, 188–230
   Google Scholar
• Circu ML, Aw TY. (2011). Redox biology of the intestine. Free Radic Res, 45, 1245–66
   PubMed Web of Science ®Google Scholar
• Cohen SM. (2010). An enhanced thirteen-week bioassay as an alternative for screening for carcinogenesis factors. Asian Pac J Cancer Prev, 11, 15–7
   PubMedGoogle Scholar
• Cohen SM, Gordon EB, Singh P, et al. (2010). Carcinogenic mode of action of folpet in mice and evaluation of its relevance to humans. Crit Rev Toxicol, 40, 531–45
   PubMed Web of Science ®Google Scholar
• Collins BJ, Stout MD, Levine KE, et al. (2010). Exposure to hexavalent chromium resulted in significantly higher tissue chromium burden compared with trivalent chromium following similar oral doses to male F344/N rats and female B6C3F1 mice. Toxicol Sci, 118, 368–79
   PubMed Web of Science ®Google Scholar
• Coogan TP, Motz J, Snyder CA, et al. (1991). Differential DNA-protein crosslinking in lymphocytes and liver following chronic drinking water exposure of rats to potassium chromate. Toxicol Appl Pharmacol, 109, 60–72
   PubMed Web of Science ®Google Scholar
• Crott JW, Fenech M. (1999). Effect of vitamin C supplementation on chromosome damage, apoptosis and necrosis ex vivo. Carcinogenesis, 20, 1035–41
   PubMed Web of Science ®Google Scholar
• Cupo DY, Wetterhahn KE. (1985). Binding of chromium to chromatin and DNA from liver and kidney of rats treated with sodium dichromate and chromium(III) chloride in vivo. Cancer Res, 45, 1146–51
   PubMed Web of Science ®Google Scholar
• Dahm LJ, Jones DP. (2000). Rat jejunum controls luminal thiol-disulfide redox. J Nutr, 130, 2739–45
   PubMed Web of Science ®Google Scholar
• Dana Devi K, Rozati R, Saleha Banu B, et al. (2001). In vivo genotoxic effect of potassium dichromate in mice leukocytes using comet assay. Food Chem Toxicol, 39, 859–65
   PubMed Web of Science ®Google Scholar
• De Flora S. (1978). Metabolic deactivation of mutagens in the Salmonella-microsome test. Nature, 271, 455–6
   PubMedGoogle Scholar
• De Flora S. (2000). Threshold mechanisms and site specificity in chromium(VI) carcinogenesis. Carcinogenesis, 21, 533–41
   PubMed Web of Science ®Google Scholar
• De Flora S, Badolati GS, Serra D, et al. (1987). Circadian reduction of chromium in the gastric environment. Mutat Res, 192, 169–74
   PubMed Web of Science ®Google Scholar
• De Flora S, Bagnasco M, Serra D, Zanacchi, P. (1990). Genotoxicity of chromium compounds. A review. Mutat Res, 238, 99–172
   PubMed Web of Science ®Google Scholar
• De Flora S, Bianchi V, Levis AG. (1984). Distinctive mechanisms for interaction of hexavalent and trivalent chromium with DNA? Toxicol Environ Chem, 8, 287–94
   Web of Science ®Google Scholar
• De Flora S, Camoirano A, Bagnasco M, et al. (1997). Estimates of the chromium(VI) reducing capacity in human body compartments as a mechanism for attenuating its potential toxicity and carcinogenicity. Carcinogenesis, 18, 531–7
   PubMed Web of Science ®Google Scholar
• De Flora S, D’Agostini F, Balansky R, et al. (2008). Lack of genotoxic effects in hematopoietic and gastrointestinal cells of mice receiving chromium(VI) with the drinking water. Mutat Res, 659, 60–7
   PubMed Web of Science ®Google Scholar
• De Flora S, Iltcheva M, Balansky RM. (2006). Oral chromium(VI) does not affect the frequency of micronuclei in hematopoietic cells of adult mice and of transplacentally exposed fetuses. Mutat Res, 610, 38–47
   PubMed Web of Science ®Google Scholar
• De Flora S, Morelli A, Basso C, et al. (1985). Prominent role of DT-diaphorase as a cellular mechanism reducing chromium(VI) and reverting its mutagenicity. Cancer Res, 45, 3188–96
   PubMed Web of Science ®Google Scholar
• DeSesso JM, Jacobson CF. (2001). Anatomical and physiological parameters affecting gastrointestinal absorption in humans and rats. Food Chem Toxicol, 39, 209–28
   PubMed Web of Science ®Google Scholar
• DeVita VT, Lawrence TS, Rosenberg SA. (2011). DeVita, Hellman, and Rosenberg's cancer: principles and practice of oncology. 9th ed. Philadelphia (PA): Lippincott Williams & Wilkins
   Google Scholar
• Di Bona, KR, Love S, Rhodes NR, et al. (2011). Chromium is not an essential trace element for mammals: effects of a “low-chromium” diet. J Biol Inorg Chem, 16, 381–90
   PubMed Web of Science ®Google Scholar
• Donaldson RM Jr, Barreras RF. (1966). Intestinal absorption of trace quantities of chromium. J Lab Clin Med, 68, 484–93
   PubMed Web of Science ®Google Scholar
• Dressman JB, Berardi RR, Dermentzoglou LC, et al. (1990). Upper gastrointestinal (GI) pH in young, healthy men and women. Pharm Res, 7, 756–61
   PubMed Web of Science ®Google Scholar
• Duncan AM, Heddle JA, Blakey DH. (1985). Mechanism of induction of nuclear anomalies by gamma-radiation in the colonic epithelium of the mouse. Cancer Res, 45, 250–2
   Google Scholar
• Ellinger-Ziegelbauer H, Stuart B, Wahle B, et al. (2004). Characteristic expression profiles induced by genotoxic carcinogens in rat liver. Toxicol Sci, 77, 19–34
   PubMed Web of Science ®Google Scholar
• Ellinger-Ziegelbauer H, Stuart B, Wahle B, et al. (2005). Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver. Mutat Res, 575, 61–84
   PubMed Web of Science ®Google Scholar
• Farkas B, Boldizsar F, Tarjanyi O, et al. (2009). BALB/c mice genetically susceptible to proteoglycan-induced arthritis and spondylitis show colony-dependent differences in disease penetrance. Arthritis Res Ther, 11, R21
   PubMedGoogle Scholar
• Febel H, Szegedi B, Huszar S. (2001). Absorption of inorganic, trivalent and hexavalent chromium following oral and intrajejunal doses in rats. Acta Vet Hung, 49, 203–9
   PubMed Web of Science ®Google Scholar
• Fenech M, Kirsch-Volders M, Natarajan AT, et al. (2011). Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells. Mutagenesis, 26, 125–32
   PubMed Web of Science ®Google Scholar
• Feng Y, Bommer GT, Zhao J, et al. (2011). Mutant KRAS promotes hyperplasia and alters differentiation in the colon epithelium but does not expand the presumptive stem cell pool. Gastroenterology, 141, 1003–1013, e1–10
   PubMed Web of Science ®Google Scholar
• Forbes SA, Tang G, Bindal N, et al. (2010). COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer. Nucleic Acids Res, 38, D652–7
   PubMed Web of Science ®Google Scholar
• Franco R, Cidlowski JA. (2009). Apoptosis and glutathione: beyond an antioxidant. Cell Death Differ, 16, 1303–14
   PubMed Web of Science ®Google Scholar
• Gardner JD, Sloan S, Robinson M, Miner PB Jr. (2004). Frequency analyses of gastric pH in control and gastro-oesophageal reflux disease subjects treated with a proton-pump inhibitor. Aliment Pharmacol Ther, 20, 1381–6
   PubMed Web of Science ®Google Scholar
• Gatto NM, Kelsh MA, Mai DH, et al. (2010). Occupational exposure to hexavalent chromium and cancers of the gastrointestinal tract: a meta-analysis. Cancer Epidemiol, 34, 388–99
   PubMed Web of Science ®Google Scholar
• Gaylor DW. (2005). Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens? Regul Toxicol Pharmacol, 41, 128–33
   PubMed Web of Science ®Google Scholar
• George MD, Wehkamp J, Kays RJ, et al. (2008). In vivo gene expression profiling of human intestinal epithelial cells: analysis by laser microdissection of formalin fixed tissues. BMC Genomics, 9, 209
   Google Scholar
• Gibb HJ, Lees PS, Pinsky PF, Rooney, BC. (2000). Clinical findings of irritation among chromium chemical production workers. Am J Ind Med, 38, 127–31
   PubMed Web of Science ®Google Scholar
• Glaser U, Hochrainer D, Kloppel H, Oldiges H. (1986). Carcinogenicity of sodium dichromate and chromium (VI/III) oxide aerosols inhaled by male Wistar rats. Toxicology, 42, 219–32
   PubMed Web of Science ®Google Scholar
• Go YM, Jones DP. (2010). Redox control systems in the nucleus: mechanisms and functions. Antioxid Redox Signal, 13, 489–509
   PubMed Web of Science ®Google Scholar
• Gold, LS, Manley NB, Slone TH, Ward JM. (2001). Compendium of chemical carcinogens by target organ: results of chronic bioassays in rats, mice, hamsters, dogs, and monkeys. Toxicol Pathol, 29, 639–52
   PubMed Web of Science ®Google Scholar
• Goldberg MT, Blakey DH, Bruce WR. (1983). Comparison of the effects of 1,2–dimethylhydrazine and cyclophosphamide on micronucleus incidence in bone marrow and colon. Mutat Res, 109, 91–8
   PubMedGoogle Scholar
• Gordon E. (2007). Captan: transition from ‘B2’ to 'not likely’. How pesticide registrants affected the EPA Cancer Classification Update. J Appl Toxicol, 27, 519–26
   Google Scholar
• Gottschling BC, Maronpot RR, Hailey JR, et al. (2001). The role of oxidative stress in indium phosphide-induced lung carcinogenesis in rats. Toxicol Sci, 64, 28–40
   PubMed Web of Science ®Google Scholar
• Grady WM, Carethers JM. (2008). Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology, 135, 1079–99
   PubMed Web of Science ®Google Scholar
• Greaves P. (2007). Histopathology of preclinical toxicity studies. 3rd ed. London: Elsevier-Academic Press
   Google Scholar
• Green PH, Cellier C. (2007). Celiac disease. N Engl J Med, 357, 1731–43
   PubMed Web of Science ®Google Scholar
• Hagen TM, Wierzbicka GT, Bowman BB, et al. (1990). Fate of dietary glutathione: disposition in the gastrointestinal tract. Am J Physiol, 259, G530–5
   PubMed Web of Science ®Google Scholar
• Haney JT, Erraguntla N, Sielken RL, Valdez-Flores C. (2012). Development of a cancer-based chronic inhalation reference value for hexavalent chromium based on a nonlinear-threshold carcinogenic assessment. Regul Toxicol Pharmacol, 64, 466–80
   PubMed Web of Science ®Google Scholar
• Harris MA, Thompson CM, Wolf JC, et al. (2012). Assessment of genotoxic potential of Cr(VI) in the intestine via in vivo intestinal micronucleus assay and in vitro high content analysis in differentiated and undifferentiated Caco-2. Society of Toxicology. San Francisco, CA
   Google Scholar
• Henics T, Wheatley DN. (1999). Cytoplasmic vacuolation, adaptation and cell death: a view on new perspectives and features. Biol Cell, 91, 485–98
   PubMed Web of Science ®Google Scholar
• Hirose T, Kondo K, Takahashi Y, et al. (2002). Frequent microsatellite instability in lung cancer from chromate-exposed workers. Mol Carcinog, 33, 172–80
   PubMed Web of Science ®Google Scholar
• Holmes AL, Wise SS, Wise JP Sr. (2008). Carcinogenicity of hexavalent chromium. Indian J Med Res, 128, 353–72
   PubMed Web of Science ®Google Scholar
• Howard WR, Hoffman SA, Kochhar TS. (1992). Enhanced production of micronuclei by hexavalent chromium in cultured CHO cells. Bull Environ Contam Toxicol, 49, 535–40
   Google Scholar
• IARC. (1990). Chromium, nickel and welding, IARC Monogr. Eval Carcinog Risks Hum, 49, 1–648
   PubMedGoogle Scholar
• Itoh S, Shimada H. (1998). Bone marrow and liver mutagenesis in lacZ transgenic mice treated with hexavalent chromium. Mutat Res, 412, 63–7
   PubMed Web of Science ®Google Scholar
• Itzkovitz S, Lyubimova A, Blat IC, et al. (2012). Single-molecule transcript counting of stem-cell markers in the mouse intestine. Nat Cell Biol, 14, 106–14
   Google Scholar
• Jennette KW. (1979). Chromate metabolism in liver microsomes. Biol Trace Elem Res, 1, 55–62
   PubMedGoogle Scholar
• John LJ, Fromm M, Schulzke JD. (2011). Epithelial barriers in intestinal inflammation. Antioxid Redox Signal, 15, 1255–70
   PubMed Web of Science ®Google Scholar
• Joseph P, He Q, Umbright C. (2008). Heme-oxygenase 1 gene expression is a marker for hexavalent chromium-induced stress and toxicity in human dermal fibroblasts. Toxicol Sci, 103, 325–34
   Google Scholar
• Jung KA, Kwak MK. (2010). The Nrf2 system as a potential target for the development of indirect antioxidants. Molecules, 15, 7266–91
   PubMed Web of Science ®Google Scholar
• Kargacin B, Squibb KS, Cosentino S, et al. (1992). Comparison of the uptake and distribution of chromate in rats and mice. Biol Trace Elem Res, 36, 307–318
   Google Scholar
• Katz SA, Salem H. (1993). The toxicology of chromium with respect to its chemical speciation: a review. J Appl Toxicol, 13, 217–24
   PubMed Web of Science ®Google Scholar
• Kerger BD, Paustenbach DJ, Corbett GE, Finley BL. (1996). Absorption and elimination of trivalent and hexavalent chromium in humans following ingestion of a bolus dose in drinking water. Toxicol Appl Pharmacol, 141, 145–58
   PubMed Web of Science ®Google Scholar
• Kim J, Cha YN, Surh YJ. (2010). A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders. Mutat Res, 690, 12–23
   PubMed Web of Science ®Google Scholar
• Kinner A, Wu W, Staudt C, Iliakis G. (2008). Gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin. Nucleic Acids Res, 36, 5678–94
   PubMed Web of Science ®Google Scholar
• Kirman CR, Aylward LL, Suh M, et al. (accepted). Physiologically based pharmacokinetic model for humans orally exposed to chromium. Chem Biol Interact
   Google Scholar
• Kirman CR, Hays SM, Aylward LL, et al. (2012). Physiologically based pharmacokinetic model for rats and mice orally exposed to chromium. Chem Biol Interact, 200, 45–64
   PubMed Web of Science ®Google Scholar
• Kirsch-Volders M, Elhajouji A, Cundari E, Van Hummelen P. (1997). The in vitro micronucleus test: a multi-endpoint assay to detect simultaneously mitotic delay, apoptosis, chromosome breakage, chromosome loss and non-disjunction. Mutat Res, 392, 19–30
   PubMed Web of Science ®Google Scholar
• Kirsch-Volders M, Plas G, Elhajouji A, et al. (2011). The in vitro MN assay in 2011: origin and fate, biological significance, protocols, high throughput methodologies and toxicological relevance. Arch Toxicol, 85, 873–99
   PubMed Web of Science ®Google Scholar
• Klaunig JE, Kamendulis LM. (2008). Chemical carcinogens (C. D. Klaassen). 7th ed. New York (NY): McGraw-Hill
   Google Scholar
• Klaunig JE, Kamendulis LM, Hocevar BA. (2010). Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol, 38, 96–109
   PubMed Web of Science ®Google Scholar
• Klein CB, Su L, Bowser D, Leszczynska J. (2002). Chromate-induced epimutations in mammalian cells. Environ Health Perspect, 110, 739–43
   PubMed Web of Science ®Google Scholar
• Knudsen I. (1980). The mammalian spot test and its use for the testing of potential carcinogenicity of welding fume particles and hexavalent chromium. Acta Pharmacol Toxicol (Copenh), 47, 66–70
   PubMedGoogle Scholar
• Kondo K, Hino N, Sasa M, et al. (1997). Mutations of the p53 gene in human lung cancer from chromate-exposed workers. Biochem Biophys Res Commun, 239, 95–100
   PubMed Web of Science ®Google Scholar
• Kopec AK, Kim S, Forgacs AL, et al. (2012a). Genome-wide gene expression effects in B6C3F1 mouse intestinal epithelia following 7 and 90 days of exposure to hexavalent chromium in drinking water. Toxicol Appl Pharmacol, 259, 13–26
   PubMed Web of Science ®Google Scholar
• Kopec AK, Thompson CM, Kim S, et al. (2012b). Comparative toxicogenomic analysis of oral Cr(VI) exposure effects in rat and mouse small intestinal epithelia. Toxicol Appl Pharmacol, 262, 124–38
   PubMed Web of Science ®Google Scholar
• Koren G. (1997). Therapeutic drug monitoring principles in the neonate. National Academy of Clinical Biochemistry. Clin Chem, 43, 222–7
   Google Scholar
• Krishnaja AP, Sharma NK. (2003). Ascorbic acid potentiates mitomycin C-induced micronuclei and sister chromatid exchanges in human peripheral blood lymphocytes in vitro. Teratog Carcinog Mutagen, Suppl 1, 99–112
   Google Scholar
• Kruidenier L, Verspaget HW. (2002). Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease–radicals or ridiculous? Aliment Pharmacol Ther, 16, 1997–2015
   PubMed Web of Science ®Google Scholar
• Kumar V, Abbas A, Fausto N. (2005). Robins and cotran pathological basis of disease. 7th ed. Philadelphia (PA): Elsevier Saunders
   Google Scholar
• Le Hegarat L, Jacquin AG, Bazin E, Fessard V. (2006). Genotoxicity of the marine toxin okadaic acid, in human Caco-2 cells and in mice gut cells. Environ Toxicol, 21, 55–64
   PubMed Web of Science ®Google Scholar
• Levin DE, Hollstein M, Christman MF, et al. (1982). A new Salmonella tester strain (TA102) with A X T base pairs at the site of mutation detects oxidative mutagens. Proc Natl Acad Sci USA, 79, 7445–9
   PubMed Web of Science ®Google Scholar
• Levina A, Lay PA. (2008). Chemical properties and toxicity of chromium(III) nutritional supplements. Chem Res Toxicol, 21, 563–71
   PubMed Web of Science ®Google Scholar
• Lipkin M, Deschner E. (1976). Early proliferative changes in intestinal cells. Cancer Res, 36, 2665–8
   PubMed Web of Science ®Google Scholar
• Lister CL, Van Schaftingen E. (2007). Vitamin C. Biosynthesis, recycling and degradation in mammals. FEBS J, 274, 1–22
   Google Scholar
• Liu KJ, Shi X. (2001). In vivo reduction of chromium (VI) and its related free radical generation. Mol Cell Biochem, 222, 41–7
   PubMed Web of Science ®Google Scholar
• Long LH, Halliwell B. (2012). The effects of oxaloacetate on hydrogen peroxed generation from ascorbate and epigallocatechin gallate in cell culture media: potential for altering cell metabolism. Biochem Biophys Res Commun, 417, 446–450
   Google Scholar
• Lu YY, Yang JL. (1995). Long-term exposure to chromium(VI) oxide leads to defects in sulfate transport system in Chinese hamster ovary cells. J Cell Biochem, 57, 655–65
   PubMed Web of Science ®Google Scholar
• Luippold RS, Mundt KA, Austin RP, et al. (2003). Lung cancer mortality among chromate production workers. Occup Environ Med, 60, 451–7
   PubMed Web of Science ®Google Scholar
• Luippold RS, Mundt KA, Dell LD, Birk T. (2005). Low-level hexavalent chromium exposure and rate of mortality among US chromate production employees. J Occup Environ Med, 47, 381–5
   Google Scholar
• Luongo C, Moser AR, Gledhill S, Dove WF. (1994). Loss of Apc+ in intestinal adenomas from Min mice. Cancer Res, 54, 5947–52
   PubMed Web of Science ®Google Scholar
• Machle W, Gregorius F. (1948). Cancer of the respiratory system in the United States chromate producing industry. Public Health Rep, 63, 1114–27
   PubMed Web of Science ®Google Scholar
• Markovich D. (2001). Physiological roles and regulation of mammalian sulfate transporters. Physiol Rev, 81, 1499–533
   PubMed Web of Science ®Google Scholar
• Marnett LJ. (2000). Oxyradicals and DNA damage. Carcinogenesis, 21, 361–70
   PubMed Web of Science ®Google Scholar
• Martensson J, Jain A, Meister A. (1990). Glutathione is required for intestinal function. Proc Natl Acad Sci USA, 87, 1715–9
   PubMed Web of Science ®Google Scholar
• Martensson J, Meister A. (1992). Glutathione deficiency increases hepatic ascorbic acid synthesis in adult mice. Proc Natl Acad Sci USA, 89, 11566–8
   PubMed Web of Science ®Google Scholar
• McCann J, Choi E, Yamasaki E, Ames BN. (1975). Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. Proc Natl Acad Sci USA, 72, 5135–9
   PubMed Web of Science ®Google Scholar
• McCarroll N, Keshava N, Chen J, et al. (2010). An evaluation of the mode of action framework for mutagenic carcinogens case study II: chromium (VI). Environ Mol Mutagen, 51, 89–111
   PubMed Web of Science ®Google Scholar
• McConnell EL, Basit AW, Murdan S. (2008). Measurements of rat and mouse gastrointestinal pH, fluid and lymphoid tissue, and implications for in-vivo experiments. J Pharm Pharmacol, 60, 63–70
   PubMed Web of Science ®Google Scholar
• Meek ME, Bucher JR, Cohen SM, et al. (2003). A framework for human relevance analysis of information on carcinogenic modes of action. Crit Rev Toxicol, 33, 591–653
   PubMed Web of Science ®Google Scholar
• Meek ME, Klaunig JE. (2010). Proposed mode of action of benzene-induced leukemia: interpreting available data and identifying critical data gaps for risk assessment. Chem Biol Interact, 184, 279–85
   PubMed Web of Science ®Google Scholar
• Meister A, Anderson ME. (1983). Glutathione. Annu Rev Biochem, 52, 711–760
   PubMed Web of Science ®Google Scholar
• Meng F, Bermudez E, McKinzie PB, et al. (2010a). Measurement of tumor-associated mutations in the nasal mucosa of rats exposed to varying doses of formaldehyde. Regul Toxicol. Pharmacol 57, 274--83
   Google Scholar
• Meng F, Knapp GW, Green T, et al. (2010b). K-Ras mutant fraction in A/J mouse lung increases as a function of benzo[a]pyrene dose. Environ Mol Mutagen, 51, 146–55
   Google Scholar
• Meunier V, Bourrie M, Berger Y, Fabre G. (1995). The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications. Cell Biol Toxicol, 11, 187–94
   PubMed Web of Science ®Google Scholar
• Miller JB. (1953). Effect of chromates on nose, throat, and ear. AMA Arch Otolaryngol, 58, 172–8
   Google Scholar
• Mimnaugh EG, Xu W, Vos M, et al. (2006). Endoplasmic reticulum vacuolization and valosin-containing protein relocalization result from simultaneous hsp90 inhibition by geldanamycin and proteasome inhibition by velcade. Mol Cancer Res, 4, 667–81
   Google Scholar
• Mirsalis JC, Hamilton CM, O’Loughlin KG, et al. (1996). Chromium (VI) at plausible drinking water concentrations is not genotoxic in the in vivo bone marrow micronucleus or liver unscheduled DNA synthesis assays. Environ Mol Mutagen, 28, 60–3
   PubMed Web of Science ®Google Scholar
• Morgan JW. (2011). Preliminary assessment of cancer occurrence in the Hinkley Census Tract, 1996–2008. Loma Linda (CA): California Cancer Registry, Loma Linda University Medical Center
   Google Scholar
• Moriarty-Craige SE, Jones DP. (2004). Extracellular thiols and thiol/disulfide redox in metabolism. Annu Rev Nutr, 24, 481–509
   PubMed Web of Science ®Google Scholar
• Morita T, MacGregor JT, Hayashi M. (2011). Micronucleus assays in rodent tissues other than bone marrow. Mutagenesis, 26, 223–30
   PubMed Web of Science ®Google Scholar
• Nagita A, Amemoto K, Yoden A, et al. (1996). Diurnal variation in intragastric pH in children with and without peptic ulcers. Pediatr Res, 40, 528–32
   PubMed Web of Science ®Google Scholar
• Natoli M, Leoni BD, D’Agnano I, et al. (2011). Cell growing density affects the structural and functional properties of Caco-2 differentiated monolayer. J Cell Physiol, 226, 1531–43
   Google Scholar
• NCI. (1977). Bioassay of Captan for Possible Carcinogenicity, CAS No. 133-06-2. National Cancer Institute CARCINOGENESIS Technical Report Series 15
   Google Scholar
• Neal MD, Richardson WM, Sodhi CP, et al. (2011). Intestinal stem cells and their roles during mucosal injury and repair. J Surg Res, 167, 1–8
   PubMed Web of Science ®Google Scholar
• Nickens KP, Patierno SR, Ceryak S. (2010). Chromium genotoxicity: a double-edged sword. Chem Biol Interact, 188, 276–88
   PubMed Web of Science ®Google Scholar
• Nishiyama K, Yao T, Yonemasu H, et al. (2002). Overexpression of p53 protein and point mutation of K-ras genes in primary carcinoma of the small intestine. Oncol Rep, 9, 293–300
   Google Scholar
• NTP (2001). NTP technical report on the toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-80-7) in F344/N rats and B6C3F1 mice (inhalation studies), NTP TR 499. NIH Publication No. 01-4433
   Google Scholar
• NTP (2002). NTP technical report on the toxicology and carcinogenesis studies of o-nitrotoluene (CAS No. 88-72-2) in F344/N rats and B6C3F1 mice (feed studies), NTP TR 504. NIH Publication No. 02-4438
   Google Scholar
• NTP (2007). National Toxicology Program technical report on the toxicity studies of sodium dichromate dihydrate (CAS No. 7789-12-0) administered in drinking water to male and female F344/N rats and B6C3F1 mice and male BALB/c and am3-C57BL/6 mice. NTP Toxicity Report Series Number 72, NIH Publication No. 07-5964
   Google Scholar
• NTP (2008a). National Toxicology Program technical report on the toxicology and carcinogenesis studies of chromium picolinate monohydrate (CAS NO. 27882-76-4) in F344/N rats and B6C3F1 mice (feed studies). NIH Publication No. 08-5897
   Google Scholar
• NTP (2008b). National Toxicology Program technical report on the toxicology and carcinogenesis studies of sodium dichromate dihydrate (CAS No. 7789-12-0) in F344/N rats and B6C3F1 mice (drinking water studies), NTP TR 546. NIH Publication No. 08-5887
   Google Scholar
• O’Brien TJ, Ceryak S, Patierno SR. (2003). Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms. Mutat Res, 533, 3–36
   PubMed Web of Science ®Google Scholar
• O’Brien TJ, Ding H, Suh M, et al. (2012). K-Ras codon 12 GGT to GAT mutation is not elevated in the duodenum of mice subchronically exposed to hexavalent chromium in drinking water. Presented at the Society of Toxicology, 2012 March 11–15. San Francisco, CA
   Google Scholar
• O’Brien TJ, Witcher P, Brooks B, Patierno SR. (2009). DNA polymerase zeta is essential for hexavalent chromium-induced mutagenesis. Mutat Res, 663, 77–83
   Google Scholar
• OECD (1997). OECD Guideline for the testing of chemicals: bacterial reverse mutation test (#471). Organisation for Economic Co-operation and Development. OECD Publishing
   Google Scholar
• OECD (2010). OECD Guideline for the testing of chemicals: in vitro mammalian cell micronucleus test (#487). 3rd ed. Organisation for Economic Co-operation and Development. OECD Publishing
   Google Scholar
• OEHHA (2011). Final technical support document on public health goal for hexavalent chromium in drinking water. Oakland (CA): Pesticide and Environmental Toxicology Branch, Office of Environmental Health Hazard Assessment, California Environmental Protection Agency
   Google Scholar
• Osburn WO, Karim B, Dolan PM, et al. (2007). Increased colonic inflammatory injury and formation of aberrant crypt foci in Nrf2-deficient mice upon dextran sulfate treatment. Int J Cancer, 121, 1883–91
   PubMedGoogle Scholar
• Park RM, Bena JF, Stayner LT, et al. (2004). Hexavalent chromium and lung cancer in the chromate industry: a quantitative risk assessment. Risk Anal, 24, 1099–108
   PubMed Web of Science ®Google Scholar
• Parry EM, Parry JM, Corso C, et al. (2002). Detection and characterization of mechanisms of action of aneugenic chemicals. Mutagenesis, 17, 509–21
   PubMed Web of Science ®Google Scholar
• Parsons BL, Manjanath MB, Myers MB, et al. (2012). Induction of cII and K-Ras mutation in lung DNA of Big Blue mice exposed to ethylene oxide by inhalation. Bellevue (WA): Environmental Mutagens Society
   Google Scholar
• Parsons BL, Myers MB, Meng F, et al. (2010). Oncomutations as biomarkers of cancer risk. Environ Mol Mutagen, 51, 836–50
   PubMed Web of Science ®Google Scholar
• Pastides H, Austin R, Lemeshow S, et al. (1994). A retrospective-cohort study of occupational exposure to hexavalent chromium. Am J Ind Med, 25, 663–75
   PubMed Web of Science ®Google Scholar
• Percy AJ, Moore, N, Chipman, JK. (1989). Formation of nuclear anomalies in rat intestine by benzidine and its biliary metabolites. Toxicology, 57, 217–23
   Google Scholar
• Peterson-Roth, E, Reynolds M, Quievryn G, Zhitkovich A. (2005). Mismatch repair proteins are activators of toxic responses to chromium-DNA damage. Mol Cell Biol, 25, 3596–607
   PubMed Web of Science ®Google Scholar
• Petrilli FL, De Flora S. (1978a). Metabolic deactivation of hexavalent chromium mutagenicity. Mutat Res, 54, 139–47
   PubMed Web of Science ®Google Scholar
• Petrilli FL, De Flora S. (1978b). Oxidation of inactive trivalent chromium to the mutagenic hexavalent form. Mutat Res, 58, 167–73
   PubMed Web of Science ®Google Scholar
• Petrilli FL, De Flora S. (1982). Interpretations on chromium mutagenicity and carcinogenicity. Prog Clin Biol Res, 109, 453–64
   Google Scholar
• Potten CS, Booth C, Pritchard DM. (1997). The intestinal epithelial stem cell: the mucosal governor. Int J Exp Pathol, 78, 219–43
   PubMed Web of Science ®Google Scholar
• Potten CS, Loeffler M. (1990). Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development, 110, 1001–20
   PubMed Web of Science ®Google Scholar
• Pozharisski KM, Kapustin YM, Likhachev AJ, Shaposhnikov JD. (1975). The mechanism of carcinogenic action of 1,2-dimethylhydrazine (SDMH) in rats. Int J Cancer, 15, 673–83
   PubMed Web of Science ®Google Scholar
• Preston RJ, Williams GM. (2005). DNA-reactive carcinogens: mode of action and human cancer hazard. Crit Rev Toxicol, 35, 673–83
   PubMed Web of Science ®Google Scholar
• Proctor DM, Suh M, Aylward LL, et al. (2012). Hexavalent chromium reduction kinetics in rodent stomach contents. Chemosphere, 89, 487–493
   PubMed Web of Science ®Google Scholar
• Proctor DM, Thompson CM, Suh M, Harris MA. (2011). A response to “A quantitative assessment of the carcinogenicity of hexavalent chromium by the oral route and its relevance to human exposure”. Environ Res, 111, 468–70; discussion 471–2
   Google Scholar
• Rahman I, MacNee W. (2000). Oxidative stress and regulation of glutathione in lung inflammation. Eur Respir J, 16, 534–54
   PubMed Web of Science ®Google Scholar
• Rawlinson LA, O’Brien PJ, Brayden DJ. (2010). High content analysis of cytotoxic effects of pDMAEMA on human intestinal epithelial and monocyte cultures. J Control Release, 146, 84–92
   PubMedGoogle Scholar
• Reynolds M, Armknecht S, Johnston T, Zhitkovich A. (2012). Undetectable role of oxidative DNA damage in cell cycle, cytotoxic and clastogenic effects of Cr(VI) in human lung cells with restored ascorbate levels. Mutagenesis, 27, 437–43
   PubMed Web of Science ®Google Scholar
• Reynolds M, Stoddard L, Bespalov I, Zhitkovich A. (2007). Ascorbate acts as a highly potent inducer of chromate mutagenesis and clastogenesis: linkage to DNA breaks in G2 phase by mismatch repair. Nucleic Acids Res, 35, 465–76
   PubMed Web of Science ®Google Scholar
• Rizk, P, Barker N. (2012). Gut stem cells in tissue renewal and disease: methods, markers, and myths. Wiley interdisciplinary reviews. Syst Biol Med, 4, 475–96
   PubMed Web of Science ®Google Scholar
• Roberts RA, Laskin DL, Smith CV, et al. (2009). Nitrative and oxidative stress in toxicology and disease. Toxicol Sci, 112, 4–16
   PubMed Web of Science ®Google Scholar
• Rodrigues CF, Urbano AM, Matoso E, et al. (2009). Human bronchial epithelial cells malignantly transformed by hexavalent chromium exhibit an aneuploid phenotype but no microsatellite instability. Mutat Res, 670, 42–52
   PubMedGoogle Scholar
• Ronen A, Heddle JA. (1984). Site-specific induction of nuclear anomalies (apoptotic bodies and micronuclei) by carcinogens in mice. Cancer Res, 44, 1536–40
   PubMed Web of Science ®Google Scholar
• Salnikow K, Zhitkovich A. (2008). Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. Chem Res Toxicol, 21, 28–44
   PubMed Web of Science ®Google Scholar
• Sambruy Y, Ferruzza S, Ranaldi G, De Angelis I. (2001). Intestinal cell culture models: applications in toxicology and pharmacology. Cell Biol Toxicol, 17, 301–17
   PubMed Web of Science ®Google Scholar
• Sarkar D, Sharma A, Talukder G. (1993). Differential protection of chlorophyllin against clastogenic effects of chromium and chlordane in mouse bone marrow in vivo. Mutat Res, 301, 33–8
   PubMed Web of Science ®Google Scholar
• Schafer FQ, Buettner GR. (2001). Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med, 30, 1191–1212
   PubMed Web of Science ®Google Scholar
• Sedelnikova OA, Redon CE, Dickey JS, et al. (2010). Role of oxidatively induced DNA lesions in human pathogenesis. Mutat Res, 704, 152–9
   PubMed Web of Science ®Google Scholar
• Sedman RM, Beaumont J, McDonald TA, et al. (2006). Review of the evidence regarding the carcinogenicity of hexavalent chromium in drinking water. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev, 24, 155–82
   PubMed Web of Science ®Google Scholar
• Seed J, Carney EW, Corley RA, et al. (2005). Overview: using mode of action and life stage information to evaluate the human relevance of animal toxicity data. Crit Rev Toxicol, 35, 664–72
   PubMed Web of Science ®Google Scholar
• Seoane AI, Dulout FN. (2001). Genotoxic ability of cadmium, chromium and nickel salts studied by kinetochore staining in the cytokinesis-blocked micronucleus assay. Mutat Res, 490, 99–106
   PubMed Web of Science ®Google Scholar
• Seoane AI, Guerci AM, Dulout FN. (2002). Malsegregation as a possible mechanism of aneuploidy induction by metal salts in MRC-5 human cells. Environ Mol Mutagen, 40, 200–6
   PubMedGoogle Scholar
• Serra S, Jani PA. (2006). An approach to duodenal biopsies. J Clin Pathol, 59, 1133–50
   PubMed Web of Science ®Google Scholar
• Shah P, Jogani V, Bagchi T, Misra, A. (2006). Role of Caco-2 cell monolayers in prediction of intestinal drug absorption. Biotechnol Prog, 22, 186–98
   PubMed Web of Science ®Google Scholar
• Shibata H, Toyama K, Shioya H, et al. (1997). Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science, 278, 120–3
   PubMed Web of Science ®Google Scholar
• Shindo Y, Toyoda Y, Kawamura K, et al. (1989). Micronucleus test with potassium chromate(VI) administered intraperitoneally and orally to mice. Mutat Res, 223, 403–6
   PubMed Web of Science ®Google Scholar
• Shrivastava R, Upreti RK, Chaturvedi UC. (2003). Various cells of the immune system and intestine differ in their capacity to reduce hexavalent chromium. FEMS Immunol Med Microbiol, 38, 65–70
   PubMed Web of Science ®Google Scholar
• Shrivastava R, Kannan A, Upreti RK, Chaturvedi UC. (2005). Effects of chromium on the resident gut bacteria of rat. Toxicol Mech Methods, 15, 211–8
   PubMed Web of Science ®Google Scholar
• Shumilla JA, Broderick RJ, Wang Y, Barchowsky A. (1999). Chromium(VI) inhibits the transcriptional activity of nuclear factor-kappaB by decreasing the interaction of p65 with cAMP-responsive element-binding protein-binding protein. J Biol Chem, 274, 36207–12
   PubMed Web of Science ®Google Scholar
• Slikker W Jr, Andersen ME, Bogdanffy MS, et al. (2004). Dose-dependent transitions in mechanisms of toxicity: case studies. Toxicol Appl Pharmacol, 201, 226–94
   PubMed Web of Science ®Google Scholar
• Smetanova L, Stetinova V, Svoboda Z, Kvetina J. (2011). Caco-2 cells, biopharmaceutics classification system (BCS) and biowaiver. Acta Medica, 54, 3–8
   Google Scholar
• Snow AD, Altmann GG. (1983). Morphometric study of the rat duodenal epithelium during the initial six months of 1,2-dimethylhydrazine carcinogenesis. Cancer Res, 43, 4838–49
   Google Scholar
• Sonich-Mullin C, Fielder R, Wiltse J, et al. (2001). IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. Regul Toxicol Pharmacol, 34, 146–52
   PubMed Web of Science ®Google Scholar
• Steinhoff D, Gad SC, Hatfield GK, Mohr U. (1986). Carcinogenicity study with sodium dichromate in rats. Exp Pathol, 30, 129–41
   PubMedGoogle Scholar
• Stern AH. (2010). A quantitative assessment of the carcinogenicity of hexavalent chromium by the oral route and its relevance to human exposure. Environ Res, 110, 798–807
   PubMed Web of Science ®Google Scholar
• Stojiljkovic V, Pejic S, Kasapovic J, et al. (2012). Glutathione redox cycle in small intestinal mucosa and peripheral blood of pediatric celiac disease patients. Anais da Academia Brasileira de Ciencias, 84, 175–84
   Google Scholar
• Stout MD, Herbert RA, Kissling GE, et al. (2009a). Hexavalent chromium is carcinogenic to F344/N rats and B6C3F1 mice after chronic oral exposure. Environ Health Perspect, 117, 716–22
   PubMed Web of Science ®Google Scholar
• Stout MD, Nyska A, Collins BJ, et al. (2009b). Chronic toxicity and carcinogenicity studies of chromium picolinate monohydrate administered in feed to F344/N rats and B6C3F1 mice for 2 years. Food Chem Toxicol, 47, 729–33
   PubMed Web of Science ®Google Scholar
• Su LK, Kinzler KW, Vogelstein B, et al. (1992). Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science, 256, 668–70
   PubMed Web of Science ®Google Scholar
• Sun H, Zhou X, Chen H, et al. (2009). Modulation of histone methylation and MLH1 gene silencing by hexavalent chromium. Toxicol Appl Pharmacol, 237, 258–66
   PubMed Web of Science ®Google Scholar
• Sun H, Clancy HA, Kluz T, et al. (2011). Comparison of gene expression profiles in chromate transformed BEAS-2B cells. PLoS One, 6, e17982
   Google Scholar
• Sunter JP, Appleton DR, Wright NA, et al. (1978). Kinetics of changes in the crypts of the jejunal mucosa of dimethylhydrazine-treated rats. Br J Cancer, 37, 662–72
   PubMedGoogle Scholar
• Sutter T, Arber N, Moss SF, et al. (1996). Frequent K-ras mutations in small bowel adenocarcinomas. Dig Dis Sci, 41, 115–8
   PubMedGoogle Scholar
• Swenberg JA, Fryar-Tita E, Jeong YC, et al. (2008). Biomarkers in toxicology and risk assessment: informing critical dose-response relationships. Chem Res Toxicol, 21, 253–65
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Kondo K, Hirose T, et al. (2005). Microsatellite instability and protein expression of the DNA mismatch repair gene, hMLH1, of lung cancer in chromate-exposed workers. Mol Carcinog, 42, 150–8
   PubMed Web of Science ®Google Scholar
• Takahashi-Yanaga F, Sasaguri T. (2007). The Wnt/beta-catenin signaling pathway as a target in drug discovery. J Pharmacol Sci, 104, 293–302
   PubMed Web of Science ®Google Scholar
• Talley NJ. (2010). Practical gastroenterology and hepatology: small and large intestine and pancreas. Hoboken (NJ): Wiley-Blackwell
   Google Scholar
• Thomas RS, Allen BC, Nong A, et al. (2007). A method to integrate benchmark dose estimates with genomic data to assess the functional effects of chemical exposure. Toxicol Sci, 98, 240–8
   PubMed Web of Science ®Google Scholar
• Thomas RS, Clewell HJ, 3rd, Allen BC, et al. (2011). Application of transcriptional benchmark dose values in quantitative cancer and noncancer risk assessment. Toxicol Sci, 120, 194–205
   PubMed Web of Science ®Google Scholar
• Thompson CM, Haws LC, Harris MA, et al. (2011a). Application of the U.S. EPA mode of action Framework for purposes of guiding future research: a case study involving the oral carcinogenicity of hexavalent chromium. Toxicol Sci, 119, 20–40
   PubMed Web of Science ®Google Scholar
• Thompson CM, Fedorov Y, Brown DD, et al. (2012a). Assessment of Cr(VI)-induced cytotoxicity and genotoxicity using high content analysis. PLoS One, 7, e42720
   PubMed Web of Science ®Google Scholar
• Thompson CM, Gregory Hixon J, Proctor DM, et al. (2012b). Assessment of genotoxic potential of Cr(VI) in the mouse duodenum: an in silico comparison with mutagenic and nonmutagenic carcinogens across tissues. Regul Toxicol Pharmacol, 64, 68–76
   PubMed Web of Science ®Google Scholar
• Thompson CM, Proctor DM, Haws LC, et al. (2011b). Investigation of the mode of action underlying the tumorigenic response induced in B6C3F1 mice exposed orally to hexavalent chromium. Toxicol Sci, 123, 58–70
   PubMed Web of Science ®Google Scholar
• Thompson CM, Proctor DM, Suh M, et al. (2012c). Comparison of the effects of hexavalent chromium in the alimentary canal of F344 rats and B6C3F1 mice following exposure in drinking water: implications for carcinogenic modes of action. Toxicol Sci, 125, 79–90
   PubMed Web of Science ®Google Scholar
• Tsapakos MJ, Hampton TH, Jennette KW. (1981). The carcinogen chromate induces DNA cross-links in rat liver and kidney. J Biol Chem, 256, 3623–6
   PubMed Web of Science ®Google Scholar
• Upham BL, Wagner JG. (2001). Toxicant-induced oxidative stress in cancer. Toxicol Sci, 64, 1–3
   PubMed Web of Science ®Google Scholar
• US EPA. (1988). Recommendations for and Documentation of Biological Values for Use in Risk Assessment. Cincinnati, OH: Office of Health and Environmental Assessment, Office of Research and Development, U.S. Environmental Protection Agency
   Google Scholar
• US EPA. (1991). National primary drinking water regulations-synthetic organic chemicals and inorganic chemicals; monitoring for unregulated contaminants; national primary drinking water regulations implementation; national secondary drinking water regulations. Final rule. Fed Regist, 56, 3526–3597
   Google Scholar
• US EPA. (1998). Toxicological review of hexavalent chromium in support of summary information on the integrated risk information system (IRIS). Washington (DC): US Environmental Protection Agency
   Google Scholar
• US EPA. (2004). Captan; cancer reclassification; amendment of reregistration eligibility decision; notice of availability. Fed Regist, 69, 68357–60
   Google Scholar
• US EPA. (2005a). Guidelines for carcinogen risk assessment, EPA/630/P-03/001F. Washington, DC: Risk Assessment Forum, U.S. Environmental Protection Agency
   Google Scholar
• US EPA. (2005b). Supplemental guidance for assessing susceptibility from early-life exposure to carcinogens, EPA/630/R-03/003F. Washington, DC: Risk Assessment Forum, US Environmental Protection Agency
   Google Scholar
• US EPA. (2007). Framework for determining a mutagenic mode of action for carcinogenicity: using EPA’s 2005 Cancer Guidelines and Supplemental Guidance for Assessing Susceptibility from Early-Life Exposure to Carcinogens. Washington, DC: US Environmental Protection Agency
   Google Scholar
• US EPA. (2009). An approach to using toxicogenomic data in U.S. EPA Human Health Risk Assessments: A Dibutyl Phthalate case study, EPA/600/R-09/028F. Washington, DC: US Environmental Protection Agency
   Google Scholar
• US EPA. (2010). Toxicological review of hexavalent chromium in support of summary information on the integrated risk information system (IRIS). External Review DRAFT. Washington, DC: US Environmental Protection Agency
   Google Scholar
• Vanhauwaert A, Vanparys P, Kirsch-Volders M. (2001). The in vivo gut micronucleus test detects clastogens and aneugens given by gavage. Mutagenesis, 16, 39–50
   Google Scholar
• Velho S, Haigis KM. (2011). Regulation of homeostasis and oncogenesis in the intestinal epithelium by Ras. Exp Cell Res, 317, 2732–9
   Google Scholar
• Vincent JB. (2000). The biochemistry of chromium. J Nutr, 130, 715–8
   PubMed Web of Science ®Google Scholar
• Vissers MC, Bozonet SM, Pearson JF, Braithwaite LJ. (2011). Dietary ascorbate intake affects steady state tissue concentrations in vitamin C-deficient mice: tissue deficiency after suboptimal intake and superior bioavailability from a food source (kiwifruit). Am J Clin Nutr, 93, 292–301
   Google Scholar
• Wang X, Son YO, Chang Q, et al. (2011). NADPH oxidase activation is required in reactive oxygen species generation and cell transformation induced by hexavalent chromium. Toxicol Sci, 123, 399–410
   Google Scholar
• Watanabe C, Egami T, Midorikawa K, et al. (2010). DNA damage and estrogenic activity induced by the environmental pollutant 2-nitrotoluene and its metabolite. Environ Health Prev Med, 15, 319–26
   Google Scholar
• Whittle BJ, Varga C. (2010). New light on the anti-colitic actions of therapeutic aminosalicylates: the role of heme oxygenase. Pharmacol Rep, 62, 548–56
   Google Scholar
• Wicki A, Herrmann R, Christofori G. (2010). Kras in metastatic colorectal cancer. Swiss Med Wkly, 140, w13112
   Google Scholar
• Wild D. (1978). Cytogenetic effects in the mouse of 17 chemical mutagens and carcinogens evaluated by the micronucleus test. Mutat Res, 56, 319–27
   PubMed Web of Science ®Google Scholar
• Williams GM. (2008). Application of mode-of-action considerations in human cancer risk assessment. Toxicol Lett, 180, 75–80
   PubMed Web of Science ®Google Scholar
• Wilson VS, Keshava N, Hester S, et al. (2011). Utilizing toxicogenomic data to understand chemical mechanism of action in risk assessment. Toxicol Appl Pharmacol, (in press)
   Google Scholar
• Yan KS, Chia LA, Li X, et al. (2012). The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations. Proc Natl Acad Sci USA, 109, 466–71
   PubMed Web of Science ®Google Scholar
• Yao H, Guo L, Jiang BH, et al. (2008). Oxidative stress and chromium(VI) carcinogenesis. J Environ Pathol Toxicol Oncol, 27, 77–88
   PubMed Web of Science ®Google Scholar
• Yilmaz OH, Katajisto P, Lamming DW, et al. (2012). mTORC1 in the Paneth cell niche couples intestinal stem-cell function to calorie intake. Nature, 486, 490–5
   PubMed Web of Science ®Google Scholar
• Younes N, Fulton N, Tanaka R, et al. (1997). The presence of K-12 ras mutations in duodenal adenocarcinomas and the absence of ras mutations in other small bowel adenocarcinomas and carcinoid tumors. Cancer, 79, 1804–8
   Google Scholar
• Zhitkovich A. (2005). Importance of chromium-DNA adducts in mutagenicity and toxicity of chromium(VI). Chem Res Toxicol, 18, 3–11
   PubMed Web of Science ®Google Scholar
• Zhitkovich A. (2011). Chromium in drinking water: sources, metabolism, and cancer risks. Chem Res Toxicol, 24, 1617–29
   PubMed Web of Science ®Google Scholar
• Zhu X, Fan WG, Li DP, et al. (2011). Heme oxygenase-1 system and gastrointestinal inflammation: a short review. World J Gastroenterol, 17, 4283–8
   PubMed Web of Science ®Google Scholar